{"url_path":"/sec/juns/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1679628/0001493152-26-024748-index.html","accession_number":"0001493152-26-024748","cik":"0001679628","ticker":"JUNS","issuer_name":"JUPITER NEUROSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1679628/0001493152-26-024748-index.html","primary_entity_key":"0001679628","primary_entity_name":"JUPITER NEUROSCIENCES, INC."},"word_count":151,"has_tables":true,"body_markdown":"**Item\n9.01. Financial Statements and Exhibits**\n\n** **\n\n**(d)\nExhibits**\n\n** **\n\n**Exhibit**\n\n**No.**\n\n \n**Description**\n\n1.1\n \n[Form of Placement Agent Agreement, dated May 20, 2026, by and between the Company and D. Boral Capital LLC.](ex1-1.htm)\n\n5.1\n \n[Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.](ex5-1.htm)\n\n10.1\n \n[Form of Securities Purchase Agreement, dated as of May 20, 2026, by and between Jupiter Neurosciences, Inc. and the purchaser parties thereto.](ex10-1.htm)\n\n23.1\n \n[Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in Exhibit 5.1).](ex5-1.htm)\n\n99.1\n \n[Pricing Press Release, May 20, 2026.](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)\n\n \n\n \n\n \n\n** **\n\n**SIGNATURES**\n\n** **\n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**JUPITER\nNEUROSCIENCES, INC.**\n\n \n \n                       \n\nDated:\nMay 21, 2026\nBy:\n*/s/\nChrister Rosen*\n\n \nName:\nChrister\nRosen\n\n \nTitle:\nChief\nExecutive Officer"}